It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Cells dedicate significant energy to build proteins often organized in multiprotein assemblies with tightly regulated stoichiometries. As genes encoding subunits assembling in a multisubunit complex are dispersed in the genome of eukaryotes, it is unclear how these protein complexes assemble. Here, we show that mammalian nuclear transcription complexes (TFIID, TREX-2 and SAGA) composed of a large number of subunits, but lacking precise architectural details are built co-translationally. We demonstrate that dimerization domains and their positions in the interacting subunits determine the co-translational assembly pathway (simultaneous or sequential). The lack of co-translational interaction can lead to degradation of the partner protein. Thus, protein synthesis and complex assembly are linked in building mammalian multisubunit complexes, suggesting that co-translational assembly is a general principle in mammalian cells to avoid non-specific interactions and protein aggregation. These findings will also advance structural biology by defining endogenous co-translational building blocks in the architecture of multisubunit complexes.
Genes encoding protein complex subunits are often dispersed in the genome of eukaryotes, raising the question how these protein complexes assemble. Here, the authors provide evidence that mammalian nuclear transcription complexes are formed co-translationally to ensure specific and functional interactions.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details






1 Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France (GRID:grid.420255.4) (ISNI:0000 0004 0638 2716); Centre National de la Recherche Scientifique (UMR7104), Illkirch, France (GRID:grid.4444.0) (ISNI:0000 0001 2112 9282); Institut National de la Santé et de la Recherche Médicale (U1258), Illkirch, France (GRID:grid.457373.1); Université de Strasbourg, Illkirch, France (GRID:grid.11843.3f) (ISNI:0000 0001 2157 9291)
2 Département Biologie Cellulaire et Infections, Computational Imaging & Modeling Unit, Institut Pasteur, Paris, France (GRID:grid.428999.7) (ISNI:0000 0001 2353 6535)
3 Medical Center-University of Freiburg, German Cancer Consortium (DKTK) partner site Freiburg, German Cancer Research, Center (DKFZ) and Department of Urology, Freiburg, Germany (GRID:grid.7708.8) (ISNI:0000 0000 9428 7911)